News | Health & Safety
18 Dec 2017 19:53
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Days of Xmas
  • Sport
  • Weather
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     18 Dec: NZ shares down, Air NZ and Contact drop
     18 Dec: Booze blunders lead to hospital for 1 in 8
     18 Dec: Retirement village for prime Auckland land
     14 Dec: Research to help small babies grow in womb
     14 Dec: Google leads way on sex advice: study
     14 Dec: Tech upgrades set for mobile surgical bus
     12 Dec: Councillors unhappy at Karori campus sale
     Top Stories

    RUGBY RUGBY
    Australia bidding for 2027 Rugby World Cup More...


    BUSINESS BUSINESS
    NZ shares down, Air NZ and Contact drop More...



     Today's News

    Rugby League:
    Crichton to depart Souths for Roosters 19:47

    Entertainment:
    Danielle Lloyd has confirmed she is to undergo gender selection to ensure her next child is a girl 19:22

    Accident and Emergency:
    Marlborough tractor crash victim named 19:07

    Politics:
    Zero Carbon Act by October: Shaw 18:57

    Entertainment:
    Carrie Fisher’s dog has been to see ‘Star Wars: The Last Jedi’, and “perked up” every time the late actress was on screen 18:52

    Entertainment:
    Sir Peter Jackson has claimed Harvey Weinstein banned him from casting Ashley Judd and Mira Sorvino in ‘The Lord of the Rings’ trilogy 18:22

    Business:
    NZ shares down, Air NZ and Contact drop 18:07

    Entertainment:
    Matt Damon has insisted people in Hollywood weren’t aware of Harvey Weinstein’s alleged behavior 17:52

    Politics:
    Soldier wins cobra strike pension fight 17:27

    Entertainment:
    Amanda Seyfried had a "better time" feeling 'Mamma Mia!: Here We Go Again' than 'Mamma Mia!' 17:22


     News Search






    Power Search


    © 2017 New Zealand City Ltd